Raymond James & Associates Care Dx, Inc. Transaction History

Raymond James & Associates

$150 Billion
Q2 2024

A detailed history of Raymond James & Associates transactions in Care Dx, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 21,149 shares of CDNA stock, worth $573,772. This represents 0.0% of its overall portfolio holdings.

Number of Shares

21,149

Previous 47,218 55.21%

Holding current value

$573,772

Previous $500,000 34.4%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$7.56 - $16.15 $197,081 - $421,014	-26,069 Reduced 55.21%	21,149 $328,000
Q1 2024 Apr 22, 2024	SELL	$7.96 - $12.37 $235,767 - $366,387	-29,619 Reduced 38.55%	47,218 $500,000
Q4 2023 Jan 16, 2024	BUY	$4.9 - $12.86 $35,623 - $93,492	7,270 Added 10.45%	76,837 $922,000
Q3 2023 Oct 24, 2023	SELL	$7.0 - $11.26 $84,868 - $136,516	-12,124 Reduced 14.84%	69,567 $486,000
Q2 2023 Jul 25, 2023	SELL	$7.61 - $9.46 $38,582 - $47,962	-5,070 Reduced 5.84%	81,691 $694,000
Q1 2023 Apr 14, 2023	BUY	$8.83 - $17.61 $31,655 - $63,131	3,585 Added 4.31%	86,761 $792,000
Q4 2022 Feb 08, 2023	SELL	$10.88 - $20.05 $760,729 - $1.4 Million	-69,920 Reduced 45.67%	83,176 $949,000
Q3 2022 Oct 25, 2022	BUY	$16.06 - $26.39 $71,691 - $117,804	4,464 Added 3.0%	153,096 $2.61 Million
Q2 2022 Aug 12, 2022	BUY	$20.49 - $39.72 $45,323 - $87,860	2,212 Added 1.51%	148,632 $3.19 Million
Q1 2022 May 11, 2022	BUY	$28.19 - $46.6 $255,598 - $422,522	9,067 Added 6.6%	146,420 $5.42 Million
Q4 2021 Feb 08, 2022	SELL	$41.2 - $73.6 $130,109 - $232,428	-3,158 Reduced 2.25%	137,353 $6.25 Million
Q3 2021 Nov 02, 2021	BUY	$59.15 - $91.99 $2.26 Million - $3.51 Million	38,168 Added 37.29%	140,511 $8.9 Million
Q2 2021 Aug 11, 2021	SELL	$63.02 - $95.11 $114,444 - $172,719	-1,816 Reduced 1.74%	102,343 $9.37 Million
Q1 2021 May 14, 2021	BUY	$57.62 - $95.6 $2.24 Million - $3.72 Million	38,888 Added 59.58%	104,159 $7.09 Million
Q4 2020 Feb 12, 2021	SELL	$41.43 - $77.09 $904,541 - $1.68 Million	-21,833 Reduced 25.07%	65,271 $4.73 Million
Q3 2020 Nov 04, 2020	SELL	$30.88 - $37.94 $485,835 - $596,910	-15,733 Reduced 15.3%	87,104 $3.31 Million
Q2 2020 Jul 28, 2020	SELL	$18.95 - $35.43 $19,537 - $36,528	-1,031 Reduced 0.99%	102,837 $3.64 Million
Q1 2020 Apr 21, 2020	SELL	$13.94 - $28.25 $409,278 - $829,420	-29,360 Reduced 22.04%	103,868 $2.27 Million
Q4 2019 Feb 12, 2020	BUY	$19.24 - $28.41 $372,524 - $550,074	19,362 Added 17.0%	133,228 $2.87 Million
Q3 2019 Nov 07, 2019	BUY	$20.03 - $40.08 $638,436 - $1.28 Million	31,874 Added 38.87%	113,866 $2.58 Million
Q2 2019 Aug 06, 2019	BUY	$25.78 - $39.77 $179,377 - $276,719	6,958 Added 9.27%	81,992 $2.95 Million
Q1 2019 May 06, 2019	BUY	$22.09 - $39.21 $1.66 Million - $2.94 Million	75,034 New	75,034 $2.37 Million

Others Institutions Holding CDNA

# of Institutions

158

Shares Held

53.5M

Call Options Held

60.8K

Put Options Held

34.9K

View Full List

About CareDx, Inc.

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.45B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

More about CDNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Care Dx, Inc. Transaction History